We are currently investigating new catalytic strategies
for the selective modification of C–H bonds in complex molecules, to enable precision molecular editing
as a drug discovery strategy.
Nitrogen-containing heterocyclic are common in pharmaceuticals and are a defining feature of alkaloid natural products. We seek to develop fundamentally new synthetic approaches with broad applicability.
Learn more
The lab's second PhD graduate, Dr. Logan Combee, has accepted a position in the Encoded Library Technology group at GSK. Congratulations Logan!
Undergraduate Kohl Ratkovich has won a Harrison Award for his work on pharmaceutically-relevant heterocycle synthesis. Congratulations Kohl!
The lab's fourth PhD graduate, Dr. Philip Hahn, has successfully defended his dissertation. He is currently deciding between several job offers.
We are a synthetic organic chemistry research laboratory at the University of Virginia.
© Copyright 2021 Michael Hilinski
